manidipine has been researched along with Cytomegalic Inclusion Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mercorelli, B | 1 |
| Luganini, A | 1 |
| Celegato, M | 1 |
| Palù, G | 1 |
| Gribaudo, G | 1 |
| Loregian, A | 1 |
1 other study available for manidipine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein.
Topics: Animals; Antiviral Agents; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Dihydropyridines; | 2018 |